ZOLL Medical, now a part of Asahi Kasei, a Japanese corporation, received FDA approval to introduce its Hospital Wearable Defibrillator (HWD) in the U.S. Intended for use on patients that may exhibit ventricular tachycardia or ventricular fibrillation (VT/VF) during their hospital stay, the HWD shares much with implantable defibrillators but can b (Read more...)